Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 14 ... According to recent research published in the journal Sleep, "We investigated if donepezil, a long-acting orally administered cholinesterase inhibitor, would reduce episodic ...
2009 NOV 16 ... Mild Cognitive Impairment (MCI). will be randomized to the intervention group, receiving donepezil, and to the control group, receiving placebo. A block randomization by four and ...
2009 SEP 21 ... in South Korea conducted a study "To evaluate the efficacy and tolerability of donepezil in patients with Binswanger type subcortical vascular dementia. Patients (n = 34, mean ...
2009 OCT 5 ... intervention for caregivers whose spouses with Alzheimer disease (AD) are taking donepezil delay nursing home (NH) placement or death of patients? Design: Randomized controlled ...
2009 NOV 2 ... impairment (MCI) trials and tested in the ADCS MCI randomized clinical trial of donepezil, vitamin E, and placebo. We assessed feasibility for its use by determining whether or ...
2009 NOV 2 ... system disease are presented in the report 'Increase of SCF plasma concentration during donepezil treatment of patients with early Alzheimer's disease.' "Alzheimer's disease (AD) can ...
2009 NOV 16 ... to evaluate the safety and efficacy of Dimebon when added to ongoing treatment with donepezil HCI tablets, the leading Alzheimer's disease (AD) medication worldwide, in patients ...
2009 NOV 16 ... as primary endpoints the potential benefits of adding dimebon to ongoing treatment with donepezil HCI tablets, the leading AD medication worldwide, on neuropsychiatric symptoms and ...
2009 OCT 12 ... is important but difficult. Cholinergic pathways are involved in these side effects, and donepezil, a cholinesterase inhibitor, may be useful for improvement of cognition," wrote N.P. ...
2009 NOV 1 ... in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine' new findings in Alzheimer disease. "The study aim was ...
2009 NOV 23 ... A new study, 'Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells,' is now ...
2009 NOV 1 ... theta power during radial maze performance. Pilocarpine, nicotine, physostigmine, and donepezil antagonized the effects of scopolamine. The ameliorative effects of nicotine, ...
2009 OCT 19 ... The three cholinesterase-inhibiting drugs currently approved for use in Canada are donepezil (brand name Aricept); rivastigmine (marketed as Exelon and Exelon Patch); and ...
2009 OCT 19 ... polymorphism rs1080985 in the cytochrome P450 2D6 (CYP2D6) gene on the efficacy of donepezil in patients with mild to moderate Alzheimer disease (AD). This was a multicenter, ...
2009 OCT 12 ... disease (AD) is the commonest cause of dementia. Cholinesterase inhibitors, such as donepezil, are the drug class with the best evidence of efficacy, licensed for mild to moderate ...
2009 NOV 1 ... have shown that, as indicated by vagal stimulation, an acetylcholinesterase inhibitor donepezil, an anti-Alzheimer's disease drug, prevents progression of heart failure in rats with ...
